CORONAVIRUS MAIN PROTEASE INHIBITOR

Title:

CORONAVIRUS MAIN PROTEASE INHIBITOR

Document Type and Number:

Japanese Patent JP2023070619

Kind Code:

A

Abstract:

To provide a novel main protease inhibitor that can serve as an effective treatment agent for SARS-CoV-2 virus.SOLUTION: A coronavirus main protease inhibitor comprises at least one selected from the group consisting of cinnamon bark, ephedra, rhubarb and cherry bark or its extract as an active ingredient.SELECTED DRAWING: Figure 1

More Like This:

JP2007524633	Compounds and methods for inducing apoptosis in cancer cells
JP2011057686	PI-3 KINASE INHIBITOR PRODRUG
JP2999791	[Title of the Invention] A method for enhancing glucosyltransferase inhibitory activity

Inventors:

HARAI KENJI
HAN LI-KUN
YOSHIMI TAKASHI

Application Number:

JP2022049160A

Publication Date:

May 19, 2023

Filing Date:

March 24, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

KRACIE SEIYAKU KK

International Classes:

A61K31/353; A23L33/105; A61K36/17; A61K36/54; A61K36/708; A61K36/736; A61P31/14

Attorney, Agent or Firm:

Reiji Aihara
Rio Moriwaki

Previous Patent: Information processing system, computer program, and information processing method

Next Patent: Dibenzo[g,p]Chrysene derivative and its production method